Robert F. Rosenbluth

Bob has an extensive background of leadership, innovation, and entrepreneurship in the medical device industry. Bob is a founder of Inceptus Medical, a medical device incubator founded in 2011, and serves as President and CEO. Inceptus Medical incubated both Inari Medical (NASDAQ: NARI) where Bob was a founder, CEO and Chairman of the Board, and Okami Medical where he currently serves as CEO and Chairman of the Board. Prior to Inceptus, Inari and Okami, Bob was a founder and CEO of Sequent Medical. Sequent was acquired by Terumo Medical Corporation for $380M. Before Sequent, Bob was a founder of MicroVention, serving as President and CEO since its inception in 1997 through 2002 and as Chairman of the Board from inception through its acquisition by Terumo. Prior to founding MicroVention, he founded Advanced Surgical Intervention and served in various R&D, business development and senior management positions at Medtronic, Pfizer, and Cardiothoracic Systems. He holds a B.S. in Chemical Engineering from Columbia University, and an M.S. in Chemical Engineering and Ph.D. in Mechanical Engineering from University of California, Berkeley.